1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: COVLARL0287, NCT01706822
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HS#2011-8537, NCT01736072
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 108643, 1R21CA153594, NCT01522677
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LLOMGI-20050743, 20050743, MALIK 012009, NCT00967655
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Educational/Counseling/Training, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-009, NCT01340300
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CASE2210, NCI-2011-01280, NCT01403103
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CCCWFU 99311, U10CA081851, WFU 09-10-14, NCT01535040
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: R12-3092L, NCT01613469
|
|
9.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 134190, NCT01632020
|
|
10.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-13419, NCI-2011-0098, NCT01375699
|
|
11.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 79 Sponsor: Other Protocol IDs: Metformin CCSC, NCT01440127
|
|
12.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DCL-10-001, NCT01495663
|
|
13.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: I 191511, NCI-2011-03568, NCT01522820
|
|
14.
|
Phase: Phase I Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 10-052, R01CA134633, NCT01671592
|
|
15.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2012-1150, NCT01816659
|
|
16.
|
Phase: No phase specified Type: Health services research, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MITT02, NCT00651677
|
|
17.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: IRB 08-178, NCT01182116
|
|
18.
|
Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCC 13910, NCT01386697
|